<DOC>
	<DOCNO>NCT01688583</DOCNO>
	<brief_summary>The purpose study assess effectiveness tolerability Fentanyl matrix chronic non-cancer pain .</brief_summary>
	<brief_title>The Effectiveness Tolerability Fentanyl Matrix Chronic Non-cancer Pain ; Assessment Patient 's Pain Treatment Goal Achievement</brief_title>
	<detailed_description>This multicenter , prospective ( study patient identify follow forward time outcome study ) , open-label ( people know identity intervention ) , observational study intend examine effectiveness Fentanyl matrix degree improvement pain . Fentanyl matrix transdermal ( skin ) system provide continuous delivery fentanyl 72 hour . Fentanyl matrix administer patient chronic ( prolong ) non-cancer pain routine practice 12 week . Dose adjust accordance patient 's degree pain treatment response investigator 's judgment .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Complain chronic noncancer pain persist &gt; = 3 month Pain inadequately control previous treatment narcotic analgesic ( opium opiumlike compound potent analgesic effect , eg , tramadol , codeine , morphine , oxycodone ) Women must postmenopausal , surgically sterile , abstinent , practice effective method birth control childbearing potential Male patient agree use method birth control donate sperm 1 month last dose study drug A write informed consent study participation Experience treatment Fentanyl matrix within past 4 week No previous experience use narcotic analgesic Past current history alcohol drug abuse Can use transdermal analgesic due skin disorder Have serious psychiatric disorder complete overall study procedure questionnaire judgment investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>Chronic non-cancer pain</keyword>
	<keyword>Fentanyl matrix</keyword>
	<keyword>Transdermal system</keyword>
</DOC>